DMB Acquisition Corp. (LSAC)
LifeSci Acquisition III Corp. formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.
We intend to focus on businesses that have their primary operations located in North America in the healthcare industry. We anticipate targeting companies domiciled in North America or Europe that are developing assets in the biopharma, medical technology, digital health, and healthcare services sectors, which aligns with our management team’s experience in healthcare investing and drug development.
|Industry||Blank Check / SPAC|
250 W 55th St #3401
New York, NY 10019
|Reporting Currency||US Dollars|
|Andrew McDonald, Ph.D.||Chairman, Chief Executive Officer and Board Member|
|Michael Rice||Chief Operating Officer and Board Member|
|David Dobkin||Chief Financial Officer and Board Member|
Latest SEC Filings
|Dec 8, 2021||S-1/A||General form for registration of securities under the Securities Act of 1933|
|Oct 12, 2021||S-1/A||General form for registration of securities under the Securities Act of 1933|
|Jul 29, 2021||S-1||General form for registration of securities under the Securities Act of 1933|
|Jun 25, 2021||DRS||Draft Registration Statement|
|View All SEC Filings|